SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners (“Frazier”), a Seattle-based, healthcare-focused investment firm, announced today that it has completed its acquisition of BioMatrix Holdings, LLC (“BioMatrix” or the “Company”).
BioMatrix, headquartered in Plantation, FL, is a leading national provider of home-based infusion services with clinical expertise in neurological diseases, immunology deficiencies and transplants, as well as blood disorders. BioMatrix serves a diversified base of patients with over 2,500 physician-referral relationships across all 50 states. The Company delivers a high-touch, patient-centric model built around therapeutic centers of excellence that provide superior management of patient therapies. BioMatrix is well positioned to benefit from the continuing shift of infused therapies to the home and ambulatory setting, as well as the ongoing growth of biologic therapies requiring infusions.
Frazier is partnering with Ted and Kathee Kramm, two highly experienced industry executives in the home infusion market, to lead BioMatrix. Ted and Kathee began their careers as clinicians (pharmacist and nurse, respectively) and have scaled multiple infusion pharmacy businesses. Most notably, in 2008, they founded AxelaCare, which, over the course of a decade, grew into one of the largest providers of home infusion services in the country. Effective as of the closing, Ted will serve as Chief Executive Officer and Kathee as President of BioMatrix.
“Backing best-in-class operators is a core tenet of our investment strategy, and we are thrilled to back Ted and Kathee,” said Frazier Partner Philip Zaorski. “As they have done previously, our shared vision for this asset is to build a nationally renowned platform that puts the patient at the center of everything we do.”
Ted Kramm, CEO, said, “Frazier’s healthcare expertise and commitment to the home infusion space is outstanding. Working with Frazier, BioMatrix has aggressive plans for growth. We will expand our footprint with both new locations and acquisitions. Additionally, we will work with regional and national payers to increase our managed care penetration and add new therapies to our service offering. Kathee and I are delighted to be working with the Frazier team and are looking forward to rapid growth.”
“I have thoroughly enjoyed leading BioMatrix for the last 14 months,” said Kathee Kramm, President of BioMatrix. “During this time, along with our exceptional leadership team and additional staff, we have fully transitioned the organization into a leading home infusion provider. I look forward to Ted joining the company as CEO so I can transition my role to focus on growth and operations and execute at a high level, as we have historically.”
Cantor Fitzgerald & Co. and Goodwin Procter LLP served as Frazier’s financial advisor and legal counsel, respectively.
About Frazier Healthcare Partners
Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over $8 billion of capital for private funds and co-investment opportunities and has invested in more than 200 companies over 32 years. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier is headquartered in Seattle, WA, and invests broadly across the U.S., Canada, and Europe. For more information about Frazier, visit www.frazierhealthcare.com/home.
About BioMatrix Holdings, LLC
BioMatrix Specialty Infusion Pharmacy, an Inc. 5000 company, is a trusted, independent specialty infusion pharmacy with decades of experience. Our compassionate care team helps patients navigate the often-challenging healthcare environment. We work closely with our patients, as well as their family and their healthcare providers, throughout the patient’s journey, staying focused on continuity of care and optimal clinical outcomes. Every day, in every interaction, we are dedicated to making a difference in people's lives.
